Cameco Announces Election of Directors
SASKATOON, Saskatchewan--(BUSINESS WIRE)-- Cameco (TSX: CCO; NYSE: CCJ) has announced the election of ten board members at its annual meeting held on May 9, 2025.
Shareholders elected board members Daniel Camus, Tammy Cook-Searson, Catherine Gignac, Tim Gitzel, Marie Inkster, Kathryn Jackson, Don Kayne, Peter Kukielski, Dominique Minière and Leontine van Leeuwen-Atkins.
Voting Results for Cameco Directors
Nominee |
Votes For |
% Votes For |
Against |
% Votes Against |
Catherine Gignac |
70,619,061 |
97.18% |
2,049,126 |
2.82% |
Daniel Camus |
69,936,962 |
96.24% |
2,731,225 |
3.76% |
Tammy Cook-Searson |
72,363,467 |
99.58% |
304,720 |
0.42% |
Tim Gitzel |
72,167,157 |
99.31% |
501,030 |
0.69% |
Kathryn Jackson |
72,503,876 |
99.77% |
164,311 |
0.23% |
Marie Inkster |
71,236,979 |
98.03% |
1,431,208 |
1.97% |
Don Kayne |
71,827,240 |
98.84% |
840,947 |
1.16% |
Peter Kukielski |
72,192,226 |
99.35% |
475,960 |
0.65% |
Dominique Minière |
72,102,629 |
99.22% |
565,558 |
0.78% |
Leontine van Leeuwen-Atkins |
71,895,262 |
98.94% |
772,925 |
1.06% |
Profile
Cameco is one of the largest global providers of the uranium fuel needed to power a secure energy future. Our competitive position is based on our controlling ownership of the world’s largest high-grade reserves and low-cost operations, as well as significant investments across the nuclear fuel cycle, including ownership interests in Westinghouse Electric Company and Global Laser Enrichment. Utilities around the world rely on Cameco to provide global nuclear fuel solutions for the generation of safe, reliable, carbon-free nuclear power. Our shares trade on the Toronto and New York stock exchanges. Our head office is in Saskatoon, Saskatchewan, Canada.
As used in this news release, the terms we, us, our, the Company and Cameco mean Cameco Corporation and its subsidiaries unless otherwise indicated.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250509455513/en/
Investor inquiries
Cory Kos
306-716-6782
[email protected]
Media inquiries
Veronica Baker
306-385-5541
[email protected]
Source: Cameco Corporation
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Kiwi Ears KE4 II: Redefining a Modern Classic
- Immune Thrombocytopenic Purpura (ITP) Market Size in the 7MM is projected to grow at a significant CAGR over the forecast period of 2025-2034 | DelveInsight
- Zhejiang Wenda Pharma Announces Positive Results from Phase II Trial of Oral BET Inhibitor NHWD-870 HCl at the 2026 ESMO Annual Meeting
Create E-mail Alert Related Categories
Business Wire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share